174 related articles for article (PubMed ID: 23533368)
21. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
Johnson PT; Horton KM; Fishman EK
Radiographics; 2009; 29(5):1333-51. PubMed ID: 19755599
[TBL] [Abstract][Full Text] [Related]
22. The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results.
Romeo V; Maurea S; Guarino S; Mainenti PP; Liuzzi R; Petretta M; Cozzolino I; Klain M; Brunetti A
Abdom Radiol (NY); 2018 Aug; 43(8):2119-2129. PubMed ID: 29214448
[TBL] [Abstract][Full Text] [Related]
23. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
[TBL] [Abstract][Full Text] [Related]
25. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
Park SY; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
[TBL] [Abstract][Full Text] [Related]
27. Adenoma characterization: adrenal protocol with dual-energy CT.
Kim YK; Park BK; Kim CK; Park SY
Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
[TBL] [Abstract][Full Text] [Related]
28. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection.
Kumagae Y; Fukukura Y; Takumi K; Shindo T; Tateyama A; Kamiyama T; Kamimura K; Nakajo M
Clin Radiol; 2013 Jul; 68(7):696-703. PubMed ID: 23482305
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
Choi YA; Kim CK; Park BK; Kim B
Radiology; 2013 Feb; 266(2):514-20. PubMed ID: 23151828
[TBL] [Abstract][Full Text] [Related]
31. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
Seo JM; Park BK; Park SY; Kim CK
AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
[TBL] [Abstract][Full Text] [Related]
32. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
33. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.
Caoili EM; Korobkin M; Brown RK; Mackie G; Shulkin BL
Acad Radiol; 2007 Apr; 14(4):468-75. PubMed ID: 17368217
[TBL] [Abstract][Full Text] [Related]
34. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
35. Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography.
Wang X; Li K; Sun H; Zhao J; Zheng L; Zhang Z; Bai R; Zhang G
Onco Targets Ther; 2016; 9():6809-6817. PubMed ID: 27843331
[TBL] [Abstract][Full Text] [Related]
36. Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas.
Kim MJ; Kang KA; Kim CK; Park SY
Eur Radiol; 2023 Mar; 33(3):2218-2226. PubMed ID: 36173446
[TBL] [Abstract][Full Text] [Related]
37. [Differential diagnosis of space-occupying adrenal masses].
Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population.
Marty M; Gaye D; Perez P; Auder C; Nunes ML; Ferriere A; Haissaguerre M; Tabarin A
Eur J Endocrinol; 2018 May; 178(5):439-446. PubMed ID: 29467231
[TBL] [Abstract][Full Text] [Related]
39. Adrenal metastases: early biphasic contrast-enhanced CT findings with emphasis on differentiation from lipid-poor adrenal adenomas.
Zhu F; Zhu X; Shi H; Liu C; Xu Z; Shao M; Tian F; Wang J
Clin Radiol; 2021 Apr; 76(4):294-301. PubMed ID: 33509608
[TBL] [Abstract][Full Text] [Related]
40. [CT and MRI in the differential diagnosis of lesions of the adrenal gland].
Ghanem N; Altehoefer C; Thürl C; Bley T; Langer M
Med Klin (Munich); 2004 Aug; 99(8):447-52. PubMed ID: 15309273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]